Abstract A009: IgG4: a new tool to predict the risk of disease progression in melanoma (2016)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-a009
Publication URI: http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-a009
Type: Journal Article/Review
Parent Publication: Cancer Immunology Research
Issue: 1_Supplement
ISSN: 2326-6066